Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults—Randomized Controlled Trial

EBioMedicine

Volumn 13, Issue , 2016, Pages 190-200

  Stenman, Lotta K ^a   Lehtinen, Markus J ^a   Meland, Nils ^b   Christensen, Jeffrey E ^c   Yeung, Nicolas ^a   Saarinen, Markku T ^a   Courtney, Michael ^c   Burcelin, Rémy ^c   Lähdeaho, Marja Leena ^d   Linros, Jüri ^e   Apter, Dan ^f   Scheinin, Mika ^g   Kloster Smerud, Hilde ^b   Rissanen, Aila ^h   Lahtinen, Sampo ^a  

^a DUPONT COMPANY   (United States)

^b Smerud Medical Research International   (Norway)

^c VAIOMER SAS   (France)

^d Finn Medi Tutkimus Oy   (Finland)

^e Kerava Health Centre   (Finland)

^f VL Medi Oy Clinical Research Center   (Finland)

^g Clinical Research Services Turku   (Finland)

^h UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Clinical trial; Fiber; Obesity; Prebiotic; Probiotic; Synbiotic

Indexed keywords

BUTYRIC ACID; C REACTIVE PROTEIN; INTERLEUKIN 6; MICROCRYSTALLINE CELLULOSE; PEPTIDES AND PROTEINS; PLACEBO; PROBIOTIC AGENT; PROPIONIC ACID; UNCLASSIFIED DRUG; VALERIC ACID; ZONULIN; BIOLOGICAL MARKER; CHOLERA TOXIN;

ADULT; ARTICLE; BIFIDOBACTERIUM ANIMALIS; BODY COMPOSITION; BODY FAT; CONTROLLED STUDY; DIETARY FIBER; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FEMALE; FOOD INTAKE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; NORMAL HUMAN; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WAIST CIRCUMFERENCE; YOUNG ADULT; ADIPOSE TISSUE; BLOOD; BODY MASS; CLINICAL TRIAL; DIET THERAPY; INTESTINE FLORA; MULTICENTER STUDY; PATHOLOGY; TREATMENT OUTCOME;

ADIPOSE TISSUE; ADULT; BIOMARKERS; BODY COMPOSITION; BODY MASS INDEX; CHOLERA TOXIN; DIETARY FIBER; FEMALE; GASTROINTESTINAL MICROBIOME; HEALTHY VOLUNTEERS; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PROBIOTICS; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

EID: 85005790360     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.10.036     Document Type: Article

References (49)

1. Amar, J., Chabo, C., Waget, A., Klopp, P., Vachoux, C., Bermudez-Humaran, L.G., Smirnova, N., Berge, M., Sulpice, T., Lahtinen, S., Ouwehand, A., Langella, P., Rautonen, N., Sansonetti, P.J., Burcelin, R., Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol. Med. 3 (2011), 559–572.
2. Brillon, D.J., Zheng, B., Campbell, R.G., Matthews, D.E., Effect of cortisol on energy expenditure and amino acid metabolism in humans. Am. J. Phys. 268 (1995), E501–E513.
3. Brun, P., Castagliuolo, I., Di Leo, V., Buda, A., Pinzani, M., Palu, G., Martines, D., Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 292 (2007), G518–G525.
4. Burcelin, R., Luche, E., Serino, M., Amar, J., The gut microbiota ecology: a new opportunity for the treatment of metabolic diseases?. Front. Biosci. (Landmark Ed.) 14 (2009), 5107–5117.
5. Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A.M., Fava, F., Tuohy, K.M., Chabo, C., Waget, A., Delmee, E., Cousin, B., Sulpice, T., Chamontin, B., Ferrieres, J., Tanti, J.F., Gibson, G.R., Casteilla, L., Delzenne, N.M., Alessi, M.C., Burcelin, R., Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (2007), 1761–1772.
6. El Asmar, R., Panigrahi, P., Bamford, P., Berti, I., Not, T., Coppa, G.V., Catassi, C., Fasano, A., Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology 123 (2002), 1607–1615.
7. Fasano, A., Not, T., Wang, W., Uzzau, S., Berti, I., Tommasini, A., Goldblum, S.E., Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 355 (2000), 1518–1519.
8. Garidou, L., Pomie, C., Klopp, P., Waget, A., Charpentier, J., Aloulou, M., Giry, A., Serino, M., Stenman, L., Lahtinen, S., Dray, C., Iacovoni, J.S., Courtney, M., Collet, X., Amar, J., Servant, F., Lelouvier, B., Valet, P., Eberl, G., Fazilleau, N., Douin-Echinard, V., Heymes, C., Burcelin, R., The gut microbiota regulates intestinal CD4 T cells expressing ROR-gamma-t and controls metabolic disease. Cell Metab. 22 (2015), 100–112.
9. Gibson, G.R., Roberfroid, M.B., Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125 (1995), 1401–1412.
10. Gutsmann, T., Howe, J., Zahringer, U., Garidel, P., Schromm, A.B., Koch, M.H., Fujimoto, Y., Fukase, K., Moriyon, I., Martinez-De-Tejada, G., Brandenburg, K., Structural prerequisites for endotoxic activity in the Limulus test as compared to cytokine production in mononuclear cells. Innate Immun. 16 (2010), 39–47.
11. Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C., Sanders, M.E., Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11 (2014), 506–514.
12. Ibarra, A., Astbury, N.M., Olli, K., Alhoniemi, E., Tiihonen, K., Effects of polydextrose on different levels of energy intake. A systematic review and meta-analysis. Appetite 87 (2015), 30–37.
13. Jie, Z., Bang-Yao, L., Ming-Jie, X., Hai-Wei, L., Zu-Kang, Z., Ting-Song, W., Craig, S.A., Studies on the effects of polydextrose intake on physiologic functions in Chinese people. Am. J. Clin. Nutr. 72 (2000), 1503–1509.
14. Kadooka, Y., Sato, M., Imaizumi, K., Ogawa, A., Ikuyama, K., Akai, Y., Okano, M., Kagoshima, M., Tsuchida, T., Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur. J. Clin. Nutr. 64 (2010), 636–643.
15. Kadooka, Y., Sato, M., Ogawa, A., Miyoshi, M., Uenishi, H., Ogawa, H., Ikuyama, K., Kagoshima, M., Tsuchida, T., Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. Br. J. Nutr. 110 (2013), 1696–1703.
16. Kallio, K.A., Hatonen, K.A., Lehto, M., Salomaa, V., Mannisto, S., Pussinen, P.J., Endotoxemia, nutrition, and cardiometabolic disorders. Acta Diabetol. 52 (2015), 395–404.
17. Klein, A., Friedrich, U., Vogelsang, H., Jahreis, G., Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults. Eur. J. Clin. Nutr. 62 (2008), 584–593.
18. Kok, R.G., De Waal, A., Schut, F., Welling, G.W., Weenk, G., Hellingwerf, K.J., Specific detection and analysis of a probiotic Bifidobacterium strain in infant feces. Appl. Environ. Microbiol. 62 (1996), 3668–3672.
19. Kujala, U.M., Kaprio, J., Sarna, S., Koskenvuo, M., Relationship of leisure-time physical activity and mortality: the Finnish twin cohort. JAMA 279 (1998), 440–444.
20. Leber, B., Tripolt, N.J., Blattl, D., Eder, M., Wascher, T.C., Pieber, T.R., Stauber, R., Sourij, H., Oettl, K., Stadlbauer, V., The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study. Eur. J. Clin. Nutr. 66 (2012), 1110–1115.
21. Ley, R.E., Turnbaugh, P.J., Klein, S., Gordon, J.I., Microbial ecology: human gut microbes associated with obesity. Nature 444 (2006), 1022–1023.
22. Li, S., Guerin-Deremaux, L., Pochat, M., Wils, D., Reifer, C., Miller, L.E., NUTRIOSE dietary fiber supplementation improves insulin resistance and determinants of metabolic syndrome in overweight men: a double-blind, randomized, placebo-controlled study. Appl. Physiol. Nutr. Metab. 35 (2010), 773–782.
23. Liu, Z.H., Huang, M.J., Zhang, X.W., Wang, L., Huang, N.Q., Peng, H., Lan, P., Peng, J.S., Yang, Z., Xia, Y., Liu, W.J., Yang, J., Qin, H.L., Wang, J.P., The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trial. Am. J. Clin. Nutr. 97 (2013), 117–126.
24. Loman, T., Lallukka, T., Laaksonen, M., Rahkonen, O., Lahelma, E., Multiple socioeconomic determinants of weight gain: the Helsinki health study. BMC Public Health, 13, 2013, 259.
25. Minami, J., Kondo, S., Yanagisawa, N., Odamaki, T., Xiao, J.Z., Abe, F., Nakajima, S., Hamamoto, Y., Saitoh, S., Shimoda, T., Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial. J. Nutr. Sci., 4, 2015, e17.
26. Moreno-Navarrete, J.M., Sabater, M., Ortega, F., Ricart, W., Fernandez-Real, J.M., Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS One, 7, 2012, e37160.
27. O'neil, P.M., Smith, S.R., Weissman, N.J., Fidler, M.C., Sanchez, M., Zhang, J., Raether, B., Anderson, C.M., Shanahan, W.R., Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity (Silver Spring) 20 (2012), 1426–1436.
28. Osterberg, K.L., Boutagy, N.E., Mcmillan, R.P., Stevens, J.R., Frisard, M.I., Kavanaugh, J.W., Davy, B.M., Davy, K.P., Hulver, M.W., Probiotic supplementation attenuates increases in body mass and fat mass during high-fat diet in healthy young adults. Obesity (Silver Spring) 23 (2015), 2364–2370.
29. Pacifico, L., Bonci, E., Marandola, L., Romaggioli, S., Bascetta, S., Chiesa, C., Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease. World J. Gastroenterol. 20 (2014), 17107–17114.
30. Parnell, J.A., Reimer, R.A., Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am. J. Clin. Nutr. 89 (2009), 1751–1759.
31. Pendyala, S., Walker, J.M., Holt, P.R., A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology, 142, 2012 (1100-1.e2).
32. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., KREMPF, M., Lau, D.C., Le Roux, C.W., Violante Ortiz, R., Jensen, C.B., Wilding, J.P., Obesity, S. & Prediabetes, NNSG, A randomized, controlled trial of 3.0 mg of Liraglutide in weight management. N. Engl. J. Med. 373 (2015), 11–22.
33. Probert, H.M., Apajalahti, J.H., Rautonen, N., Stowell, J., Gibson, G.R., Polydextrose, lactitol, and fructo-oligosaccharide fermentation by colonic bacteria in a three-stage continuous culture system. Appl. Environ. Microbiol. 70 (2004), 4505–4511.
34. Putaala, H., Salusjarvi, T., Nordstrom, M., Saarinen, M., Ouwehand, A.C., Bech Hansen, E., Rautonen, N., Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclooxygenase expression. Res. Microbiol. 159 (2008), 692–698.
35. Roessler, A., Friedrich, U., Vogelsang, H., Bauer, A., Kaatz, M., Hipler, U.C., Schmidt, I., Jahreis, G., The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention. Clin. Exp. Allergy 38 (2008), 93–102.
36. Russo, F., Linsalata, M., Clemente, C., Chiloiro, M., Orlando, A., Marconi, E., Chimienti, G., Riezzo, G., Inulin-enriched pasta improves intestinal permeability and modifies the circulating levels of zonulin and glucagon-like peptide 2 in healthy young volunteers. Nutr. Res. 32 (2012), 940–946.
37. Sanchez, M., Darimont, C., Drapeau, V., Emady-Azar, S., Lepage, M., Rezzonico, E., Ngom-Bru, C., Berger, B., Philippe, L., Ammon-Zuffrey, C., Leone, P., Chevrier, G., St-Amand, E., Marette, A., Dore, J., Tremblay, A., Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. Br. J. Nutr. 111 (2014), 1507–1519.
38. Sapone, A., De Magistris, L., Pietzak, M., Clemente, M.G., Tripathi, A., Cucca, F., Lampis, R., Kryszak, D., Carteni, M., Generoso, M., Iafusco, D., Prisco, F., Laghi, F., Riegler, G., Carratu, R., Counts, D., Fasano, A., Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 55 (2006), 1443–1449.
39. Stenman, L.K., Holma, R., Korpela, R., High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids. World J. Gastroenterol. 18 (2012), 923–929.
40. Stenman, L.K., Waget, A., Garret, C., Klopp, P., Burcelin, R., Lahtinen, S., Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice. Benefic. Microbes 5 (2014), 437–445.
41. Stenman, L.K., Burcelin, R., Lahtinen, S., Establishing a causal link between gut microbes, body weight gain and glucose metabolism in humans—towards treatment with probiotics. Benefic. Microbes, 2015, 1–12 (E-pub ahead of print).
42. Stenman, L.K., Waget, A., Garret, C., Briand, F., Burcelin, R., Sulpice, T., Lahtinen, S., Probiotic B420 and prebiotic polydextrose improve efficacy of antidiabetic drugs in mice. Diabetol. Metab. Syndr., 7, 2015, 75.
43. Teixeira, T.F., Souza, N.C., Chiarello, P.G., Franceschini, S.C., Bressan, J., Ferreira, C.L., Peluzio Mdo, C., Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clin. Nutr. 31 (2012), 735–740.
44. Torgerson, J.S., Hauptman, J., Boldrin, M.N., Sjostrom, L., XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27 (2004), 155–161.
45. Tuomilehto, J., Lindstrom, J., Eriksson, J.G., Valle, T.T., Hamalainen, H., Ilanne-Parikka, P., Keinanen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., Salminen, V., Uusitupa, M., Finnish Diabetes Prevention Study, G, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344 (2001), 1343–1350.
46. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
47. Wang, W., Uzzau, S., Goldblum, S.E., Fasano, A., Human zonulin, a potential modulator of intestinal tight junctions. J. Cell Sci. 113:Pt 24 (2000), 4435–4440.
48. Zhang, D., Zhang, L., Zheng, Y., Yue, F., Russell, R.D., Zeng, Y., Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients. Diabetes Res. Clin. Pract. 106 (2014), 312–318.
49. Zunszain, P.A., Anacker, C., Cattaneo, A., Carvalho, L.A., Pariante, C.M., Glucocorticoids, cytokines and brain abnormalities in depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 35 (2011), 722–729.